Anonymous
Guest
Anonymous
Guest
SCHOOLED BIOTCH!! any other comments Jerry?
The point is Access did not meet the 20% growth that corporate was promised, you felcher. You did not beat the number you committed to. We grew our business 17% and a lot of if came right out of your bottom line. Keep believing
your own logic and we will keep chipping away.
Bard Access is the market leader in every product line. BSC has been ruined by Bard Access. Medcomp is a joke. AngioDynamics is a small player.
Take the job!